Pharmacogenomics of HIV therapy: summary of a workshop sponsored by the National Institute of Allergy and Infectious Diseases.
نویسندگان
چکیده
David W. Haas,1 Daniel R. Kuritzkes,2 Marylyn D. Ritchie,1 Shashi Amur,3 Brian F. Gage,4 Gary Maartens,5 Dan Masys,1 Jacques Fellay,6 Elizabeth Phillips,7 Heather J. Ribaudo,8 Kenneth A. Freedberg,9 Christos Petropoulos,10 Teri A. Manolio,11 Roy M. Gulick,12 Richard Haubrich,13 Peter Kim,14 Marjorie Dehlinger,14 Rahel Abebe,15 and Amalio Telenti6; on behalf of participants in the workshop, Pharmacogenomics – A Path Towards Personalized HIV Care*
منابع مشابه
WORKSHOP SUMMARY Implications of HIV PrEP Trials Results
Six randomized clinical trials have been implemented to examine the efficacy of tenofovir disoproxil fumarate (TDF) and/or TDF/emtricitabine (TDF/FTC) as preexposure prophylaxis for HIV-1 infection (PrEP). Although largely complementary, the six trials have many similar features. As the earliest results become available, an urgent question may arise regarding whether changes should be made in t...
متن کاملSummary of presentations at the NIH/NIAID New Humanized Rodent Models 2007 Workshop
It has long been recognized that a small animal model susceptible to HIV-1 infection with a functional immune system would be extremely useful in the study of HIV/AIDS pathogenesis and for the evaluation of vaccine and therapeutic strategies to combat this disease. By early 2007, a number of reports on various rodent models capable of being infected by and responding to HIV including some with ...
متن کاملA Shot at Dendritic Cell-Based Vaccine Strategy against HIV-1
Introduction: Despite considerable efforts to control AIDS pandemic, it is still one of the significant infectious concerns worldwide. The advance in medical research has led to the development of highly active antiretroviral therapy with a considerable effect to suppress the disease. However, an effective vaccine capable of eradication the HIV pandemic is not available yet. Failure to develop ...
متن کاملMetabolic Abnormalities in HIV-Positive Patients Receiving Highly Active Antiretroviral Therapy
Background and Objective: Dyslipidemia has become a common problem in human immunodeficiency virus (HIV) disease, especially in patients on combination antiretroviral therapy. In this study we aimed to determine the prevalence of dyslipidemia and metabolic abnormalities in 2 groups of HIV infected patients receiving highly activ...
متن کاملAntibody to Human Immunodeficiency Virus Type 1 (HIV-1) gp160 in Mucosal Specimens of Asymptomatic HIV-1-Infected Volunteers Parenterally Immunized with an Experimental Recombinant HIV-1 IIIB gp160 Vaccine
JOHN S. LAMBERT,* RAPHAEL VISCIDI, MARY CLARE WALKER, BARBARA CLAYMAN, MARCY WINGET, MARK WOLFF, DAVID H. SCHWARTZ, AND THE NIAID-SPONSORED AIDS VACCINE EVALUATION GROUP The Institute of Human Virology, University of Maryland at Baltimore School of Medicine, Baltimore, Maryland 21201; Schools of Hygiene and Public Health and of Medicine, Johns Hopkins University, Baltimore, Maryland 21205; Divi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- HIV clinical trials
دوره 12 5 شماره
صفحات -
تاریخ انتشار 2011